Human hepatoma cells (HuH7, Thermo Fisher Scientific),
47 mouse myoblast cells (C2, ATCC CRL-1772), and mouse neuronal cells (
NSC34, Cedarlane)
62 (
link) were seeded in 6-well plates (5 × 10
5 cells/well) and transfected with plasmids encoding
sec-hGAA (2 μg/well) using
Lipofectamine 3000 in
OPTIMEM medium (Thermo Fisher Scientific) according to the manufacturer’s instructions. A plasmid encoding EGFP under the control of the phosphoglycerate kinase (PGK) promoter (2 μg/well) was transfected as a control. 200 ng/well of the PGK-
EGFP plasmid were co-transfected with
sec-hGAA plasmids to normalize transfection efficiency. 72 hr after transfection, cells and conditioned media were harvested and analyzed for GAA enzyme activity and hGAA expression by western blot analyses. Early-passage cell cultures were used in the study.
Human skeletal muscle myoblasts (CSC-C3196, Creative Bioarray) were seeded on collagen-coated 12-well plates and infected with AAV9-
hGAA or AAV9-EGFP vectors for 2 hr in
OPTIMEM medium (Thermo Fisher Scientific) at an MOI of 2 × 10
5 vg/cell. After infection, cells were maintained using the Creative Bioarray SuperCult Skeletal Muscle Cell Growth Medium Kit supplemented with 10% fetal bovine serum and human fibroblast growth factor-2 (
FGF-2, Miltenyi Biotec). Infection was repeated twice, every 48 hr; cells were harvested 48 hr following the second infection.
Colella P., Sellier P., Costa Verdera H., Puzzo F., van Wittenberghe L., Guerchet N., Daniele N., Gjata B., Marmier S., Charles S., Simon Sola M., Ragone I., Leborgne C., Collaud F, & Mingozzi F. (2018). AAV Gene Transfer with Tandem Promoter Design Prevents Anti-transgene Immunity and Provides Persistent Efficacy in Neonate Pompe Mice. Molecular Therapy. Methods & Clinical Development, 12, 85-101.